Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Hair transplant healing boost? study tests antiseptic combo

NCT ID NCT07155408

Disease control Sponsor: Elif Asena KANTARCI Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Sep 16, 2026 · Updated 2 times

Summary

This study tested whether adding the antibiotic rifampicin to the standard antiseptic povidone-iodine could improve wound healing and prevent infection after hair transplantation. 65 adults were randomly assigned to receive either the combination or the standard antiseptic alone. Researchers tracked infection rates and healing time over 14 days after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Povidone-Iodine and Rifampicin
What this could lead to
If it works, this could lead to a simple, low-cost way to reduce infections and speed up healing after hair transplants.
What could go wrong
This is a small, single-center study with only 65 participants. Results may not apply to everyone, and adding an antibiotic could increase the risk of resistance or allergic reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

70 people

The number who actually took part.

Started

Dec 2021

Finished

Jun 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male participants older than 20 years * Scheduled for a first hair transplantation session * Deemed medically fit for the procedure * Provided written informed consent Exclusion Criteria: * Diabetes or another chronic or systemic condition that could affect wound healing * Heart failure or kidney failure * Communicable disease * Scalp disorder * Recent antibiotic use * Planned second hair transplantation session * Absence of a medical fitness report * Medication, antibiotic, rifamycin, or topical-solution allergy relevant to the protocol

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Androgenetic alopecia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

alopecia androgenetic alopecia injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Androgenetic alopecia Wound healing

Contacts and locations

Locations

  • Bahcesehir University, School of Health Sciences, Department of Nursing

    Istanbul, Besiktas, 34353, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.